The reduction of the EPHB2 levels has been found to correlate with the degree of malignancy, as a significant decrease in number of EPHB2 positive cells and in staining intensity has been observed at the adenoma-carcinoma transition [5,18,19]. This evidence concerns the gene EPHB2 and adenoma.